# Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy.

- **DOI:** [10.1038/s41366-023-01295-4](https://doi.org/10.1038/s41366-023-01295-4)
- **Rating:** Limited (2.6 out of 5)
- **Verdict:** Early-pregnancy metabolomics identifies two C-peptide-associated candidates, but cross-sectional evidence cannot establish the proposed causal pathway.
- **Framework version:** v5.13
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-11-13
- **Evaluation page:** https://www.nabu.science/paper/10.1038%2Fs41366-023-01295-4

## Key claims

1. palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses
   - Support: Supported
   - Type: Primary finding
   - Basis: cross-sectional associations persist after full-feature FDR correction, without independent replication
   - Location: Abstract, Results
2. We conclude that the metabolome of pregnant women with overweight/obesity is already altered early in pregnancy because of associated changes of C-peptide.
   - Support: Tentative
   - Type: Secondary
   - Basis: contemporaneous observational measurements and incomplete confounding control cannot establish the proposed causal pathway
   - Location: Abstract, Conclusions
3. After stringent analysis, 15 metabolites associated with at least one exposure (BMI, leptin, glucose, C-peptide, ISHOMA)
   - Support: Tentative
   - Type: Secondary
   - Basis: same-sample selection and unadjusted multivariable testing leave most candidates without full-feature multiplicity-adjusted support
   - Location: Abstract, Results; Table 2
4. Leptin (p < 0.001) and C-peptide (p = 0.009) concentrations were significantly increased, and insulin sensitivity decreased (p = 0.002) in the group with overweight-obesity compared to the underweight-normal weight group.
   - Support: Supported
   - Type: Secondary
   - Basis: reported group comparisons support these differences within a selected cross-sectional cohort
   - Location: Results, Study participants
5. Two metabolites: tryptamine and 2,3,4,9-tetrahydro-1H-carboline-3-carboxylic acid were inversely associated with ISHOMA [in the overweight-obesity sub-cohort]. The association remained significant in multivariable analysis after adjusting for confounders (Table 5).
   - Support: Tentative
   - Type: Secondary
   - Basis: small subgroups of nine and 23 participants leave adjusted exploratory associations vulnerable to small-sample uncertainty
   - Location: Results, The metabolome in healthy or unhealthy obesity; Table 5

## Strengths

- **Two candidates survive broader multiplicity control** Palmitoleoyl ethanolamide and N-acetyl-L-alanine remain associated with C-peptide in the all-feature analysis as well as the adjusted models. This supports their prioritisation for subsequent research, not independent replication.
  - Dimension: contribution
  - Location: Results, Robustness of the results; Tables 2–3
- **Fasting sampling with biochemical smoking verification** Blood was collected after overnight fasting, and inclusion required both self-reported non-smoking and undetectable serum cotinine. These procedures reduce variation associated with recent intake and smoking.
  - Dimension: methodological rigour
  - Location: Methods, Sample collection and analyses
- **Findings situated within pregnancy metabolism literature** The paper distinguishes first-trimester questions from later-pregnancy evidence and explains how untargeted profiling extends earlier targeted analyses of the same cohort.
  - Dimension: positioning
  - Location: Introduction; Discussion

## Limitations

- **Causal interpretation lacks timing and confounding control** C-peptide and metabolites were measured contemporaneously, so the asserted causal direction is not identified. Adjustment for gestational age, maternal age and processing time does not resolve plausible confounding by adiposity or diet.
  - Dimension: methodological rigour
  - Location: Methods, Sample collection and analyses; Multivariable regression analysis; Abstract Conclusions
- **Stringent candidate framing exceeds exploratory evidence** The 15 candidates were selected and tested in the same cohort without multiplicity adjustment of the selected multivariable tests, while only two retained the highlighted exposure associations in the full-feature analysis. Generalisation is also restricted by unexamined selection from a termination-clinic, non-smoking population containing only six women with obesity.
  - Dimension: reporting
  - Location: Methods, Participants and Multivariable regression analysis; Abstract Results; Tables 2–3
- **Reported effect size changes across locations** The abstract gives N-acetyl-L-alanine an effect size of 7%, whereas Table 2 reports R² = 0.18, equivalent to 18%. That changes the stated magnitude by 11 percentage points, although the positive association and reported p < 0.001 remain.
  - Dimension: methodological rigour
  - Location: Abstract Results; Table 2, N-acetyl-L-alanine row

## Reliability checks

Concerns (4 of 4 checks).

- **Results check:** Concern
  - palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses (95% CI: 0.10-0.34; effect size: 21%; p < 0.001; 95% CI: 0.04-0.10; effect size: 7%; p < 0.001): "95% CI: 0.04-0.10; effect size: 7%; p < 0.001" (Abstract, Results) vs "N-acetyl-L-alanine0.070.04 to 0.100.18<0.001" (Table 2, N-acetyl-L-alanine row). Table 2 labels effect size as R², so 0.18 corresponds to 18%, which is 11 percentage points above the abstract's 7%. → Changes the size materially
  - Minor reporting notes (3):
    - Descriptive: "15S-hydroperoxy-11Z,13E-eicosadienoic acid−0.12−0.21 to −0.300.170.019" (Table 2, 15S-hydroperoxy-11Z,13E-eicosadienoic acid row). Neither ordering of the printed endpoints −0.21 and −0.30 contains the point estimate −0.12. → Effect on result unclear
    - Descriptive: "gestational age [median, IQR]: 7+0, 7+5 – 8+5 weeks" (Results, Study participants). The reported median of 7+0 weeks equals 49 days and falls below the stated IQR of 54–61 days. → Effect on result unclear
    - Descriptive: "Metabolites (n = 19) identified in the pre-selection step (Supplementary Table 1)" (Materials, Participants and Methods, Sub-cohort analysis—healthy and unhealthy obesity) vs "A total of 24 annotated metabolites were significantly associated with at least one exposure (BMI, leptin, glucose, C-peptide and ISHOMA) at the pre-selection step (Supplementary Table 1)." (Results, Selection of metabolite candidates). The Methods and Results give different counts, 19 and 24, for metabolites identified at the pre-selection step while referring to the same supplementary table. → Effect on result unclear
- **Reporting and transparency:** Noted. Ethics approval is declared, including one approval before recruitment and another dated after the reported collection window. The text does not establish whether the later approval was an amendment.
  - Ethics approval: declared
- **Reference integrity:** Clean. 54 of 54 checkable references verified
  - 55 references in manuscript
  - 1 are books, websites or datasets — counted, but not index-checkable
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-11-13
